Skip to main content
. 2021 Jul 23;12:708904. doi: 10.3389/fmicb.2021.708904

TABLE 1.

Antibacterial activities of all the lead new cyclic lipopeptides 2605-4 and 2612-8.1 are reported in comparison with colistin and vancomycin in μg/mL.

Cyclic lipo-peptides (CLP) MIC 90 (μg/mL)
MRSA P. aeruginosa A. baumannii
2605-4 3.1–6.25 >100 6.25–12.5
2612-8.1 12.5–25 12.5–25 6.25–12.5
Colistin >100 *ND <0.78
Vancomycin 12.5-25 *ND >100

*ND: Not determined.